MarketScreener Strategies DexCom, Inc.
Stocks
DXCM
US2521311074
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
00:00:00 14/08/2026 +04
|
Pre-market 15:00:22 | |||
| 91.48 USD | +0.75% |
|
89.98 | -1.64% |
| 08-13 | Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating | MT |
| 08-04 | Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating | MT |
MarketScreener Strategies
Search
 | DexCom comes under fire from accusations | September 23, 2025 at 11:24 am |
 | DexCom's competitive edge: Innovation and market expansion | August 21, 2025 at 02:17 pm |
| Dexcom: the bloodbath | July 26, 2024 at 01:20 pm |
 | DexCom, Inc. : A Must-Have Tool for Diabetes Care | July 10, 2024 at 05:17 pm |
 | DexCom is still in the running | March 07, 2024 at 01:49 pm |
No results match your criteria
Filters
- Stock Market
- Stocks
- DXCM Stock
- News DexCom, Inc.
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
